TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›SOLV›Financials
Annual statements · SEC XBRL · FY2022 – FY2025

Solventum Corp (SOLV) financials

Income statement

Solventum Corp (SOLV) income statement, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$8.13B$8.20B$8.25B$8.32B
Revenue growth—0.8%0.7%0.9%
Gross profit$4.70B$4.69B$4.59B$4.45B
Gross margin57.7%57.3%55.6%53.5%
Operating income$1.69B$1.69B$1.04B$2.18B
Operating margin20.8%20.6%12.6%26.2%
Net income$1.34B$1.35B$479M$1.56B
Net margin16.5%16.4%5.8%18.7%
EPS (diluted)$7.78$7.79$2.76$8.88

Cash flow

Solventum Corp (SOLV) cash flow, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow$1.68B$1.92B$1.19B$369M
Capital expenditures$251M$290M$380M$379M
Free cash flow$1.43B$1.63B$805M-$10.0M

Balance sheet

Solventum Corp (SOLV) balance sheet, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents$61.0M$194M$762M$878M
Total assets—$13.9B$14.5B$14.3B
Total liabilities—$2.28B$11.5B$9.24B
Long-term debt—$0.00$7.81B$5.04B
Shareholders' equity$11.7B$11.7B$2.96B$5.05B
Retained earnings—$0.00$242M$1.80B
Shares (wtd avg diluted)173M173M174M175M

Every figure is extracted from Solventum Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Solventum Corp's annual revenue?
Solventum Corp (SOLV) reported $8.32B of revenue for fiscal year 2025 — up 0.9% from $8.25B in FY2024, per its annual report filed with the SEC.
Is Solventum Corp profitable?
Yes — SOLV earned $1.56B of net income in FY2025, a 18.7% net margin, per SEC filings.
What is Solventum Corp's free cash flow?
-$10.0M in FY2025 (operating cash flow $369M minus $379M of capital expenditures), from the SEC cash-flow statement.
Does SOLV pay a dividend?
Solventum Corp reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full SOLV analysis — verdict, score & filings →Is SOLV a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.